Kalaris Therapeutics, Inc. Common Stock Share Price
NASDAQ: KLRS
Live Kalaris Therapeutics, Inc. Common Stock Share Price Chart
O H L
Kalaris Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$3.16Low
$3.16High
Markets Today
| Previous Close | $3.16 |
|---|---|
| Open | $3.16 |
| Volume | 4,056 |
| Day's Range | $3.16 - $3.16 |
| 52W Range | NA |
| Market Cap | $75.70 M |
Historical Performance
| 1M Returns | -21.59 |
|---|---|
| 3M Returns | -33.05 |
| 6M Returns | -58.03 |
| 1Y Returns | -28.02 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Kalaris Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $75.70 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-46.14 M |
| Profit Margin | N/A |
| Market Cap | $75.70 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-46.14 M |
| Profit Margin | N/A |
Kalaris Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$10.35 M | -$12.26 M | -$12.74 M | -$10.80 M | -$11.83 M | -$12.39 M |
| EBITDA | -$10.35 M | -$12.26 M | -$12.74 M | -$10.79 M | -$11.82 M | -$12.38 M |
| Interest Expense | -$1.44 M | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $0 | $0 | $3.00 K | $10.00 K | $10.00 K | $10.00 K |
| Income Before Tax | -$10.20 M | -$11.35 M | -$11.89 M | -$10.00 M | -$10.86 M | -$11.52 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$10.20 M | -$11.35 M | -$11.89 M | -$10.00 M | -$10.86 M | -$11.52 M |
| Net Profit Margin | - | - | - | - | - | - |
Kalaris Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$126.76 M | -$138.11 M | -$150.00 M | -$159.99 M | -$170.90 M | -$182.44 M |
| Non-Current Liabilities | $32.08 M | $32.08 M | $33.24 M | $33.21 M | $33.17 M | $33.13 M |
| Current Liabilities | $7.14 M | $7.65 M | $6.07 M | $9.71 M | $8.08 M | $8.74 M |
| Total Liabilities | $39.22 M | $39.73 M | $39.31 M | $42.92 M | $41.25 M | $41.87 M |
| Fixed Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Assets | $102.18 M | $91.65 M | $78.18 M | $118.81 M | $98.47 M | $95.92 M |
| Total Assets | $103.09 M | $92.84 M | $81.17 M | $121.74 M | $109.81 M | $99.54 M |
Kalaris Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$10.20 M | -$11.35 M | -$11.89 M | -$10.00 M | -$10.86 M | -$11.52 M |
| Operating Cash Flow | -$7.44 M | -$12.54 M | -$11.33 M | -$7.06 M | -$11.58 M | -$11.05 M |
| Investing Cash Flow | $0 | $0 | -$34.71 M | $14.98 M | -$50.35 M | $20.17 M |
| Financing Cash Flow | $107.27 M | $0 | $0 | $47.74 M | -$1.70 M | -$377.00 K |
| Change in Cash | $99.83 M | -$12.54 M | -$46.04 M | $55.67 M | -$63.63 M | $8.75 M |
Kalaris Therapeutics, Inc. Common Stock Return Calculator
The Kalaris Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Kalaris Therapeutics, Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
Popular Stocks
FAQs
What is the share price of Kalaris Therapeutics, Inc. Common Stock today?
Kalaris Therapeutics, Inc. Common Stock (KLRS) share price as of September 18, 2026 is $3.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Kalaris Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Kalaris Therapeutics, Inc. Common Stock (KLRS) Share by opening an international trading account with Angel One.
How can I purchase Kalaris Therapeutics, Inc. Common Stock shares in India?
Purchasing Kalaris Therapeutics, Inc. Common Stock (KLRS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Kalaris Therapeutics, Inc. Common Stock (KLRS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Kalaris Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Kalaris Therapeutics, Inc. Common Stock (KLRS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Kalaris Therapeutics, Inc. Common Stock?
The market capitalization of Kalaris Therapeutics, Inc. Common Stock on September 18, 2026, is $75.70 M.
In which sector Kalaris Therapeutics, Inc. Common Stock belongs?
Kalaris Therapeutics, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Kalaris Therapeutics, Inc. Common Stock stocks?
In order to invest in Kalaris Therapeutics, Inc. Common Stock (KLRS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
